Fig. 6From: Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathwaysA The expressions of p-EGFR, HRAS, p-MAP2K1, and p-ERK1/2. B Syringin decreased their expression of them in MCF-7 cells. C Syringin decreased their expression of them in MDA-MB-231 cells. *P < 0.05 and **P < 0.01Back to article page